🔗 Share this article

A shadow economy for unapproved slimming drugs is being driven by TikTok fitness influencers and vendors on communication apps, according to new investigations.

Experimental Treatment Gaining Traction Via Social Media

Retatrutide, which remains in clinical trials, is being advertised by social media influencers for its alleged fat-burning properties. Followers are urged to contact these profiles directly for supplier links, while also obtaining discount codes.

Active Trade on Messaging Platforms

Separately, a flourishing market exists on messaging services, where groups with numerous of participants share “before and after” photos, administration instructions and claims of next-day UK delivery. Sellers promote the substance there before redirecting buyers to WhatsApp for transactions.

Understanding Retatrutide

This medication is an investigational injectable created by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Early trials indicate it could help individuals reduce up to 25% of their total weight. Nicknamed the “triple G”, the substance is being promoted online as the next Ozempic.

Healthcare Experts Express Concerns

Nevertheless, doctors and chemists have warned that the sale of what is still an unapproved medication in the UK is worrisome and could lead to users injecting substances of unknown origin.

Some experts said the popularity for retatrutide could be linked to the rising price of approved weight loss products such as Mounjaro.

Regulatory Status and Implementation

Marketing retatrutide on social media or messaging apps is prohibited in the UK, as it is an unlicensed drug that must not be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.

Several content creators attempt to sidestep the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and distribution can still violate medicines, advertising, and customer laws, potentially leading to penalties, prosecution or imprisonment.

Platform Response and Content Elimination

According to the social media company, the service has taken down problematic content and prohibited associated keywords and query recommendations. The organization said it was dedicated to keeping the service safe and investing in strengthening enforcement strategies.

Online Trading Operations

Investigations also discovered groups with up to 9,000 members selling the experimental drug using the platform's built-in search feature, which functions like a public directory. Typing “retatrutide” immediately brings up groups with thousands of users, filled with images of weight loss, positive testimonials and detailed instructions for mixing or administering at residence.

Within minutes of entering one group, a vendor posted contact information, where most purchases occur. The vendor provided an instruction manual and guaranteed shipping within 48 hours. When asked whether the product was authentic, one seller responded: “You can’t be sure.” Another shared a photo of a supposed testing documentation. None inquired about weight, medical conditions or previous experience.

Product Details and Costs

Within these communities, messages display dark colored packages with postal service labels, claiming to include fresh supplies. One message stated: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, prepared at home with sterile water, or pre-filled injectors usually priced at £160 for 20mg. When questioned how long a pen should last, sellers give conflicting answers ranging from a few weeks to “depends on your body”.

Service Oversight and Security Measures

A representative for the messaging service stated it actively monitored harmful material on its platform including content that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“Individuals are injecting substances they cannot confirm. Even if the science behind retatrutide is valid, these digital versions may not contain what they claim,” said Jason Murphy, the head of pharmacy at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor connected the increase in interest to recent cost increases for approved slimming medications such as Mounjaro. “With prices increasing, individuals are using social media. But counterfeit injections are highly risky. You cannot know what’s inside or whether the environment they were produced in was clean,” she explained.

Her team has already encountered individuals harmed by self-injection from unconfirmed sources. “We understand the frustration, but buying from Telegram or communication platforms is gambling with your well-being,” stated Wyllie. “These materials could be impure or incorrectly dosed.”

Producer Statement

A representative from Eli Lilly stated retatrutide was in third stage research studies and had not been reviewed or approved by any government authority globally. “Therefore at this point no one can sell [it] for human use,” they said, adding that any product “misleadingly claiming itself as a Lilly investigational substance not yet approved … may expose users to possibly serious health risks”.